Literature DB >> 2471080

Multiple conductance channels in type-2 cerebellar astrocytes activated by excitatory amino acids.

M M Usowicz1, V Gallo, S G Cull-Candy.   

Abstract

L-GLUTAMATE and L-aspartate are thought to have a widespread function as synaptic transmitters in the mammalian central nervous system and there are at least three types of neuronal glutamate receptors, which can be activated by the selective agonists N-methyl-D-aspartate (NMDA), quisqualate and kainate. Recent experiments indicate that glutamate receptors also occur in astrocytes. We have used patch-clamp methods to determine whether one type of macroglial cell, the type-2 astrocyte, possesses glutamate receptors, as previously proposed from neurochemical studies. We find that glutamate and related amino acids can evoke whole-cell and single-channel currents in type-2 astrocytes from rat cerebellum. Although these cells are found mainly in white matter, where neurotransmission does not occur, their processes are closely associated with axons at nodes of Ranvier, suggesting that such receptors are involved in neuronal-glial signalling at the node. Our experiments show that glial cells possess quisqualate- and kainate-receptor channels but lack receptors for NMDA. Interestingly, these glutamate channels exhibit multiple conductance levels that are similar in amplitude to the neuronal glutamate channels.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2471080     DOI: 10.1038/339380a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  37 in total

1.  Electrophysiology of glutamate and sodium co-transport in a glial cell of the salamander retina.

Authors:  E A Schwartz; M Tachibana
Journal:  J Physiol       Date:  1990-07       Impact factor: 5.182

Review 2.  Modes of glutamate receptor gating.

Authors:  Gabriela K Popescu
Journal:  J Physiol       Date:  2011-11-21       Impact factor: 5.182

Review 3.  The pain of tendinopathy: physiological or pathophysiological?

Authors:  Ebonie Rio; Lorimer Moseley; Craig Purdam; Tom Samiric; Dawson Kidgell; Alan J Pearce; Shapour Jaberzadeh; Jill Cook
Journal:  Sports Med       Date:  2014-01       Impact factor: 11.136

4.  Chronic encephalopathies induced by mercury or lead: aspects of underlying cellular and molecular mechanisms.

Authors:  L Rönnbäck; E Hansson
Journal:  Br J Ind Med       Date:  1992-04

5.  Transient increase in glutamic acid decarboxylase mRNA in the cerebral cortex following focal cortical lesion in the rat.

Authors:  A Najlerahim; D G Showell; R C Pearson
Journal:  Exp Brain Res       Date:  1991       Impact factor: 1.972

6.  Organic electronics for precise delivery of neurotransmitters to modulate mammalian sensory function.

Authors:  Daniel T Simon; Sindhulakshmi Kurup; Karin C Larsson; Ryusuke Hori; Klas Tybrandt; Michel Goiny; Edwin W H Jager; Magnus Berggren; Barbara Canlon; Agneta Richter-Dahlfors
Journal:  Nat Mater       Date:  2009-07-05       Impact factor: 43.841

7.  Cloning and in situ localization of a brain-derived porin that constitutes a large-conductance anion channel in astrocytic plasma membranes.

Authors:  R Dermietzel; T K Hwang; R Buettner; A Hofer; E Dotzler; M Kremer; R Deutzmann; F P Thinnes; G I Fishman; D C Spray
Journal:  Proc Natl Acad Sci U S A       Date:  1994-01-18       Impact factor: 11.205

8.  Neurotransmitter receptors and voltage-dependent Ca2+ channels encoded by mRNA from the adult corpus callosum.

Authors:  C Matute; R Miledi
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-15       Impact factor: 11.205

9.  Pharmacological characterization of glutamate binding sites in cultured cerebellar granule cells and cortical astrocytes.

Authors:  I Holopainen; P Saransaari; S S Oja
Journal:  Neurochem Res       Date:  1994-02       Impact factor: 3.996

10.  Interactions between valproate, glutamate, aspartate, and GABA with respect to uptake in astroglial primary cultures.

Authors:  M Nilsson; E Hansson; L Rönnbäck
Journal:  Neurochem Res       Date:  1992-04       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.